seminar 08-10-2008 - effects of bone on fat mass
TRANSCRIPT
Montreal 2008Montreal 2008
Effects of bone on fat Effects of bone on fat massmass
Highlights ASBMR, part Highlights ASBMR, part 22
Montreal 2008Montreal 2008
Effects of bone on fat Effects of bone on fat massmass
Highlights ASBMR, part Highlights ASBMR, part 22
Dr. E. van der VeerDr. E. van der Veer
University Medical Center GroningenUniversity Medical Center Groningen
Utrecht, Oct 8Utrecht, Oct 8TH TH 20082008
ASBMRASBMRASBMRASBMR
ASBMR
Effects of Effects of fat massfat mass on on boneboneEffects of Effects of fat massfat mass on on bonebone Fat mass imposes mechanical stress on boneFat mass imposes mechanical stress on bone Adipocytes secretes biologically active moleculesAdipocytes secretes biologically active molecules
EstrogenEstrogen ResistinResistin LeptinLeptin Adiponectin Adiponectin Interleukin – 6 (IL-6)Interleukin – 6 (IL-6)
Pancreas secretes bone-active hormonesPancreas secretes bone-active hormones InsulinInsulin AmylinAmylin PreptinPreptin
Adipocytes and osteoblasts have common progenitor, Adipocytes and osteoblasts have common progenitor, the pluripotent mesenchymal stem cellthe pluripotent mesenchymal stem cell
ASBMR
Osteoblasts and Osteoblasts and adipocytes adipocytes
originate from originate from common common
progenitor-progenitor-mesenchymal stem mesenchymal stem
cellscells
Osteoblasts and Osteoblasts and adipocytes adipocytes
originate from originate from common common
progenitor-progenitor-mesenchymal stem mesenchymal stem
cellscells
Rosen et al 2006
Zhao et al 2008
ASBMR
Effects of Effects of bonebone on on fatfat massmassEffects of Effects of bonebone on on fatfat massmassHormones that regulate fat/glucose metabolism have
effects on the skeleton,
But does bone regulate the energy homeostasis?
Mice with increased levels of uncarboxylated osteocalcin (uOC) are protected from type 2 diabetes regulating adiponectin secretion,
Mice lacking osteocalcin display decreased B-cell proliferation, glucose intolerance and insulin resistance
(Lee NG et al, Cell 2007,130:458).
ASBMR
Effects of Effects of bonebone on on fat massfat massEffects of Effects of bonebone on on fat massfat mass SA 444 SA 444 Osteocalcin and ObesityOsteocalcin and Obesity SpagnoliSpagnoli
Obese and Post Gastric By-pass patientsObese and Post Gastric By-pass patients
SU 461SU 461 Osteocalcin and type II DiabetesOsteocalcin and type II Diabetes NguyenNguyenMen aged 60+
SU 459SU 459 Osteocalcin and Fat Mass /Glucose KindblomElderly Swedish Men
SU 225SU 225 Osteocalcin gene and Osteocalcin gene and Body Fat MassBody Fat Mass McGuiganMcGuiganElderly Swedish WomenElderly Swedish Women
SA 198SA 198 Osteocalcin and Carotid Plaques / Metabolic Syndrome Waern
ASBMR
OsteocalcinOsteocalcinOsteocalcinOsteocalcinProtein of 49 amino acidsProtein of 49 amino acids
3 glutamin residues3 glutamin residues
After carboxylation of the After carboxylation of the
GLU-residues binding to hydroxyapatiteGLU-residues binding to hydroxyapatite
ASBMR
VITAMIN K CYCLEVITAMIN K CYCLE..VITAMIN K CYCLEVITAMIN K CYCLE..
ORAL ANTICOAGULANTS INHIBIT THE RECYCLING OF VITAMIN K
‘Inactive’ OSTEOCALCIN
OSTEOCALCIN
ASBMR
Seeman et al. NEJM 2006
Bone turnoverBone turnover
PINPBALPOsteocalcine
CTxCrosslinks
TRAP
ASBMR
Effects of Effects of bonebone on on fat massfat massEffects of Effects of bonebone on on fat massfat mass SA 444 SA 444 Osteocalcin and ObesityOsteocalcin and Obesity SpagnoliSpagnoli
Obese and Post Gastric By-pass patientsObese and Post Gastric By-pass patients
SU 461SU 461 Osteocalcin and type II DiabetesOsteocalcin and type II Diabetes NguyenNguyenMen aged 60+
SU 459SU 459 Osteocalcin and Fat Mass /Glucose KindblomElderly Swedish Men
SU 225SU 225 Osteocalcin gene and Osteocalcin gene and Body Fat MassBody Fat Mass McGuiganMcGuiganElderly Swedish WomenElderly Swedish Women
SA 198SA 198 Osteocalcin and Carotid Plaques / Metabolic Syndrome Waern
ASBMR
Background:In obese patients with diabetes, gastric bypass surgery (GBS) through unknown mechanisms, leads to ~90% resolution of type 2 diabetes before any significant weight loss occurs.
SA 444 SA 444 Osteocalcin and ObesityOsteocalcin and ObesitySpagnoliSpagnoli
SA 444 SA 444 Osteocalcin and ObesityOsteocalcin and ObesitySpagnoliSpagnoli
ASBMR
Study is designed to determine: 1) uOC levels in obese patients with and without diabetes 2) the effect of Gastric By-pass Surgery on uOC
3) the relationship of uOC with adiponectin and in turn with insulin sensitivity.
SA 444 SA 444 Osteocalcin and ObesityOsteocalcin and Obesity
SpagnoliSpagnoli SA 444 SA 444 Osteocalcin and ObesityOsteocalcin and Obesity
SpagnoliSpagnoli
ASBMR
40 obese patients (BMI: 48.5±9.7 kg/m2)
- 19 had type 2 diabetes,- 12 patients that had GBS 12-24 months prior to the study (post-GBS)
(BMI: 29±7 kg/m2); - 16 normal weight age-matched control subjects (BMI: 25±3.3 kg/m2).
Measured:glucose and insulin to determine HOMA, (Homeostatic model assessment
for quantifying insulin resistance) serum total and uncarboxylated osteocalcin, serum HMW-adiponectin by RIA or IRMA.
SA 444 SA 444 Osteocalcin and ObesityOsteocalcin and ObesitySpagnoliSpagnoli
SA 444 SA 444 Osteocalcin and ObesityOsteocalcin and ObesitySpagnoliSpagnoli
ASBMR
SA 444 SA 444 Osteocalcin and Osteocalcin and ObesityObesity
SpagnoliSpagnoli
SA 444 SA 444 Osteocalcin and Osteocalcin and ObesityObesity
SpagnoliSpagnoli
ASBMR
Inverse correlation was found between:uOC and HMW-adiponectin r = -0.28 p=0.02 uOC and HOMA r = -0.33 p=0.006 HMW-adiponectin and HOMA r = -0.32 p=0.008
ConclusionIn obese patients uOC levels are decreased, and normalize post-GBS.
These data support the hypothesis that uOC is a bone hormone that regulates insulin sensitivity by modulating adiponectin.
Spagnoli et al postulate that normalization of uOC is a mechanism for diabetes resolution post-GBS.
SA 444 SA 444 Osteocalcin and ObesityOsteocalcin and ObesitySpagnoliSpagnoli
SA 444 SA 444 Osteocalcin and ObesityOsteocalcin and ObesitySpagnoliSpagnoli
ASBMR
Effects of Effects of bonebone on on fat massfat massEffects of Effects of bonebone on on fat massfat mass SA 444 Osteocalcin and Obesity Spagnoli
Obese and Post Gastric By-pass patients
SU 461 Osteocalcin and type II Diabetes Nguyen
Men aged 60+
SU 459 Osteocalcin and Fat Mass /Glucose Kindblom
Elderly Swedish Men
SA 198 Osteocalcin and Carotid Plaques / Metabolic Syndrome Waern
SU 225 Osteocalcin gene and Body Fat Mass McGuigan
Elderly Women
ASBMR
SU 461 Osteocalcin and type II DiabetesNguyen
SU 461 Osteocalcin and type II DiabetesNguyen
Background: Serum osteocalcin (OC), a 49-amino acid bone matrix protein, has
recently been shown to be associated with diabetes in mice. However, it is unknown whether the association is present in men.
Aim: Therefore, this study sought to examine the contribution of OC to the
susceptibility of type II diabetes in men
ASBMRSerum OC, sex hormone binding globulin (SHBG), 25(OH)D, and PTH were measured by radioimmunoassay in 443 men aged 60+ at baseline (1989) in the Dubbo Osteoporosis Epidemiology Study. The men’s health status, including fracture and diabetes, had been monitored between 1989 and 2007. Bone mineral density (BMD), clinical risk factors, and lifestyle factors had also been obtained at baseline and subsequent biannual visits.
ASBMR
ASBMR
ASBMR
ASBMR
SU 461 Osteocalcin and type II DiabetesNguyen
SU 461 Osteocalcin and type II DiabetesNguyen
Conclusion Osteocalcin and serum testosteron were independent
risk factors for type II diabetes Thus, these data suggest that lower osteocalcin were
associated with an increased risk of type II diabetes in men.
The use of serum OC may help improve the prognostic accuracy of type II diabetes in men.
ASBMR
Effects of Effects of bonebone on on fat massfat massEffects of Effects of bonebone on on fat massfat mass SA 444 Osteocalcin and Obesity Spagnoli
Obese and Post Gastric By-pass patients
SU 461 Osteocalcin and type II Diabetes Nguyen
SU 459 Osteocalcin and Fat Mass /Glucose Kindblom
Elderly Swedish Men
SA 198 Osteocalcin and Carotid Plaques / Metabolic Syndrome Waern
SU 225 Osteocalcin gene and Body Fat Mass McGuigan
Elderly Women
ASBMR
Background: Osteocalcin affect adiposity and glucose homeostasis in
mice, suggesting that the skeleton via an endocrine mechanism influences energy metabolism.
Aim: To investigate the relationship between plasma
osteocalcin and parameters reflecting fat mass and glucose homeostasis in humans.
SU 459 Osteocalcin and Fat Mass /Glucose Kindblom
ASBMR
SU 459 Osteocalcin and Fat Mass /Glucose Kindblom
SU 459 Osteocalcin and Fat Mass /Glucose Kindblom
Methods:Methods:1010 elderly men (75.3± 3.2 years) of the MrOS Sweden study, 1010 elderly men (75.3± 3.2 years) of the MrOS Sweden study,
non-diabetic n= 857 non-diabetic n= 857 diabetic n= 153. diabetic n= 153.
Fasting levels were analysed of Fasting levels were analysed of plasma osteocalcin, plasma osteocalcin, plasma glucose, plasma glucose, serum insulin and serum insulin and lipidslipids
Fat mass and lean mass were analysed using dual energy X-ray Fat mass and lean mass were analysed using dual energy X-ray absorptiometry. absorptiometry.
ASBMR
SU 459 Osteocalcin and Fat Mass /Glucose Kindblom
SU 459 Osteocalcin and Fat Mass /Glucose Kindblom
BMI
Total body fat
Glucose
(fasting)
ASBMR
Pearson’s correlation coefficients for associations with Osteocalcin
ASBMR
ASBMR
SU 459 Osteocalcin and Fat Mass /Glucose Kindblom
ASBMR
ASBMR
SU 459 Osteocalcin and Fat Mass /Glucose Kindblom
SU 459 Osteocalcin and Fat Mass /Glucose Kindblom
PINPPINP is strongly associated with is strongly associated with OsteocalcinOsteocalcin
Pearson’s r = 0.66Pearson’s r = 0.66
Both bone formation markers were included together as Both bone formation markers were included together as covariates in linear regression models:covariates in linear regression models:
OC was independently predicting glucose and fat mass,OC was independently predicting glucose and fat mass,
but PINP not.but PINP not.
ASBMR
ASBMR
SU 459 Osteocalcin and Fat Mass /Glucose Kindblom
SU 459 Osteocalcin and Fat Mass /Glucose Kindblom
Conclusion:Conclusion: Osteocalcin is a negative predictor of fat mass and Osteocalcin is a negative predictor of fat mass and
plasma glucose in elderly menplasma glucose in elderly men In contrast, PINP is not an independent predictor In contrast, PINP is not an independent predictor
These human data support recently published These human data support recently published experimental studies, revealing endocrine functions of experimental studies, revealing endocrine functions of osteoblast-derived osteocalcin on glucose and fat osteoblast-derived osteocalcin on glucose and fat homeostasis.homeostasis.
ASBMR
Effects of Effects of bonebone on on fat massfat massEffects of Effects of bonebone on on fat massfat mass SA 444 Osteocalcin and Obesity Spagnoli
Obese and Post Gastric By-pass patients
SU 461 Osteocalcin and type II Diabetes Nguyen
SU 459 Osteocalcin and Fat Mass /Glucose Kindblom
Elderly Swedish Men
SU 225 Osteocalcin gene and Body Fat Mass McGuigan
Elderly Swedish Women
SA 198 Osteocalcin and Carotid Plaques / Metabolic Syndrome Waern
ASBMR
SU 225 Osteocalcin gene and Body Fat MassMcGuigan
SU 225 Osteocalcin gene and Body Fat MassMcGuigan
Aim: To determine the relationship between variation in the
osteocalcin gene with bone density, fracture and body fat parameters
Methods: 1044 elderly women all 75 years old at baseline
Follow-up 9 years
ASBMR
SU 225 Osteocalcin gene and Body Fat MassMcGuigan
SU 225 Osteocalcin gene and Body Fat MassMcGuigan
4 SNPs around Osteocalcin locus on Chr 1,including rs1800247 located in the promoter rs 2842880 in intron 13
rs 933489 in intron 14
ASBMR
SU 225 Osteocalcin gene and Body Fat MassMcGuigan
SU 225 Osteocalcin gene and Body Fat MassMcGuigan
• Osteocalcin SNP’s were associated with % total body fat at baseliners1800247 located in the promoter (p=0.045)rs 2842880 in intron 13 (p=0.009)
• No longer significant after correction for height
Changes in body fat between baseline and 5 years follow-up
The heterozygotes appeared to loose the most fat mass.
ASBMR
SU 225 Osteocalcin gene and Body Fat MassMcGuigan
SU 225 Osteocalcin gene and Body Fat MassMcGuigan
Conclusion: The variation in the osteocalcin gene is linked both to
BMD and to fracture in elderly Caucasian women
Interestingly, we can not exclude an independent influence of the variation in the osteocalcin gene on changes in fat mass
ASBMR
Effects of Effects of bonebone on on fat massfat massEffects of Effects of bonebone on on fat massfat mass SA 444 Osteocalcin and Obesity Spagnoli
Obese and Post Gastric By-pass patients
SU 461 Osteocalcin and type II Diabetes Nguyen
SU 459 Osteocalcin and Fat Mass /Glucose Kindblom
Elderly Swedish Men
SU 225 Osteocalcin gene and Body Fat Mass McGuigan
Elderly Swedish Women
SA 198 Osteocalcin and Carotid Plaques / Metabolic Syndrome Waern
Elderly
ASBMR
SA 198 Osteocalcin and Carotid Plaques / Metabolic Syndrome Waern
SA 198 Osteocalcin and Carotid Plaques / Metabolic Syndrome Waern
Aim:To investigate the relationship between
osteocalcin and indicators of the metabolic syndrome
Methods: 619 randomly selected 70 years old men and women longitudinal study with examinations at age 70, 76 och 86
ASBMR
Results• Osteocalcin increased by 44 percent from 70 to 86 years of age.
This increase was related to, but independent of, declining kidney function (cystatin C) increasing PTH.
• Inverse correlation was found between:OC and BMDOC and BMIin both sexes at all ages investigated (P<0.05).
OC adjusted for BMI:OC and insulin r = -0.11 p<0.01OC and glucose r = -0.25 p<0.0001
A multiple regression model (diabetes excluded) with osteocalcin as dependent variable showed that glucose, (but not insulin), waist circumference and BMD were independent indirect predictors While PTH, cystatin C and ALP were independent direct predictors of osteocalcin (p <0.001).
SA 198 Osteocalcin and Carotid Plaques / Metabolic Syndrome Waern
SA 198 Osteocalcin and Carotid Plaques / Metabolic Syndrome Waern
ASBMR
OC was inversely related to the risk of having bilateral carotoid plaques (OR per SD increase in osteocalcin 0.68 (95% CI 0.47 - 0.97)).
The risk for stroke within 15 years after the age of 70 was increased in men with low serum osteocalcin (p<0.01).
Low osteocalcin increased the risk of having high waist circumference (Men > 102 cm, women > 88 cm; OR per SD increase in osteocalcin 0.77 (0.67-0.89).
Low osteocalcin predicted the parameters of the metabolic syndrome high waist circumference, (p<0.01) BMI >30, high triglycerides, hypertension diabetes.
SA 198 Osteocalcin and Carotid Plaques / Metabolic Syndrome Waern
SA 198 Osteocalcin and Carotid Plaques / Metabolic Syndrome Waern
ASBMR
Conclusion:
Low serum osteocalcin predicts high glucose and carotid plaques and indicators of the metabolic syndrome.
SA 198 Osteocalcin and Carotid Plaques / Metabolic Syndrome Waern
SA 198 Osteocalcin and Carotid Plaques / Metabolic Syndrome Waern
ASBMR
bone regulates the energy
homeostasis
bone regulates the energy
homeostasis
ASBMR 2008
osteocalcin
ASBMR
Central Regulation of Bone Central Regulation of Bone RemodelingRemodeling
interaction between bone and braininteraction between bone and brain
Central Regulation of Bone Central Regulation of Bone RemodelingRemodeling
interaction between bone and braininteraction between bone and brain
Rosen 2008
Cell Metab
Baldock et al 2007
Lundberg et al 2007
Sato et al 2007
Lee et al 2007
ASBMRMet dank aan de Nederlandse collegae voor de leerzame discussies tijdens de ASBMR
ASBMR
ASBMR
Diabetic subjects had lower plasma osteocalcin (-21.7 %, p< 0.001) Diabetic subjects had lower plasma osteocalcin (-21.7 %, p< 0.001) than non-diabetic subjects. than non-diabetic subjects.
For both all subjects and non-diabetic subjects, plasma osteocalcin For both all subjects and non-diabetic subjects, plasma osteocalcin was clearly inversely related to BMI, fat mass and plasma glucose was clearly inversely related to BMI, fat mass and plasma glucose (p< 0.001), while it was not associated with height or lean mass. (p< 0.001), while it was not associated with height or lean mass.
Plasma osteocalcin explained a substantial part (6.3%) of the Plasma osteocalcin explained a substantial part (6.3%) of the variance in plasma glucose while it associated moderately with variance in plasma glucose while it associated moderately with serum insulin. serum insulin.
Multiple linear regression models adjusting for serum insulin and fat Multiple linear regression models adjusting for serum insulin and fat mass demonstrated that plasma osteocalcin was an independent mass demonstrated that plasma osteocalcin was an independent negative predictor of plasma glucose (p< 0.001).negative predictor of plasma glucose (p< 0.001).
ASBMR
Methods and population619 randomly selected 70 years old men and women
longitudinal study with examinations at age 70, 76 och 86.
BMD was measured in calcaneus with dual photon absorptiometry and
osteocalcin was analysed by a double-antibody radioimmuno-assay.
Serum was sampled after 10 hours fasting and non-smoking in the morning.
Extra- and intracranial circulation was examined by means of duplex sonography and Transcranial Doppler techniques in 142 subjects at age 78.